Malaysia's IHH Offers To Buy Fortis At Higher Price Than Manipal Hospitals
Mumbai: Fortis Healthcare Ltd said on Friday Malaysia's IHH Healthcare Berhad has offered to buy the company at Rs 160 ($2.45) per share, paving the way to a better bid than Manipal Hospitals.
Manipal Hospitals Enterprises Pvt Ltd offered to buy Fortis, which is among the country's largest hospital operators, at Rs 155 per share earlier this week. The offer didn't impress Fortis's minority shareholders, including equity investor Rakesh Jhunjhunwala, who called the price "low".
IHH, one of Asia's largest healthcare operators, made an "unsolicited non-binding expression of interest" to Fortis for a "possible due diligence and participation with the company", Fortis said in a statement on Friday.
In the IHH letter, which Fortis made public, the former said it was making the offer due to the "inability of the statutory auditors of (Fortis) to opine on its financial position as at December 31, 2017, and regulatory investigations that are currently underway."
Fortis has also received an investment offer worth Rs 1,250 ($191.5 million) from Hero Enterprise Investment Office and the Burman Family Office - private investment arm of the family that owns consumer goods firm Dabur India, the company had said on Thursday.
Fortis is under investigations by the Serious Fraud Investigations Office and the Securities and Exchange Board of India regarding financial fraud. The company's Chief Executive Bhavdeep Singh said last month he expects the probes to be over within the next 12 months.
Â
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
